Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Empower Neuromodulation System for the Treatment of Alcohol Use Disorder

NCT05948605 is registered in ClinicalTrials.gov with Theranova, L.L.C. as lead sponsor.

NCT NCT05948605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05948605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Empower Neuromodulation System for the Treatment of Alcohol Use Disorder
Lead sponsor
Theranova, L.L.C.
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2023
Completion date
August 6, 2025
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, alcohol use disorder, alcoholism